Group One Trading’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-9,855
Closed -$505K 7535
2024
Q3
$564K Buy
+9,855
New +$565K ﹤0.01% 2763
2023
Q4
Sell
-9,213
Closed -$347K 7692
2023
Q3
$352K Buy
9,213
+4,057
+79% +$166K ﹤0.01% 3277
2023
Q2
$186K Buy
5,156
+4,115
+395% +$140K ﹤0.01% 4010
2023
Q1
$39.8K Buy
+1,041
New +$48.8K ﹤0.01% 5023
2019
Q4
Sell
-9,752
Closed -$169K 5296
2019
Q3
$151K Buy
+9,752
New +$161K ﹤0.01% 3278
2019
Q1
Sell
-23,364
Closed -$379K 5020
2018
Q4
$342K Sell
23,364
-57,369
-71% -$915K ﹤0.01% 2264
2018
Q3
$1.47M Buy
80,733
+33,757
+72% +$591K 0.01% 1395
2018
Q2
$792K Buy
46,976
+25,604
+120% +$484K 0.01% 1919
2018
Q1
$419K Buy
+21,372
New +$414K ﹤0.01% 2196
2016
Q4
Sell
-44,038
Closed -$482K 4573
2016
Q3
$532K Sell
44,038
-12,143
-22% -$124K 0.01% 1772
2016
Q2
$485K Sell
56,181
-2,781
-5% -$27.4K 0.01% 1755
2016
Q1
$558K Sell
58,962
-92,004
-61% -$866K 0.01% 1605
2015
Q4
$2.62M Sell
150,966
-35,821
-19% -$571K 0.03% 691
2015
Q3
$2.51M Buy
186,787
+56,132
+43% +$1.13M 0.03% 653
2015
Q2
$2.95M Buy
130,655
+10,408
+9% +$183K 0.04% 539
2015
Q1
$1.72M Buy
120,247
+111,864
+1,334% +$1.61M 0.03% 724
2014
Q4
$81K Buy
+8,383
New +$74.5K ﹤0.01% 3010
2014
Q3
Sell
-53,064
Closed -$505K 5265
2014
Q2
$524K Buy
53,064
+5,275
+11% +$44.8K 0.01% 1610
2014
Q1
$607K Sell
47,789
-157,195
-77% -$2.33M 0.01% 1488
2013
Q4
$3.07M Buy
204,984
+1,257
+0.6% +$16.2K 0.05% 425
2013
Q3
$2.25M Buy
203,727
+123,857
+155% +$1.03M 0.04% 495
2013
Q2
$635K Buy
+79,870
New +$509K 0.02% 1151

Other funds holding HALO

Group One Trading's HALO Position: Q4 2024 in Review

Group One Trading sold out of Halozyme (HALO) in Q4 2024, closing a stake of 9,855 shares — an estimated $505K sold.

Group One Trading first reported a position in HALO in Q2 2013 and held it in 22 quarters. The position peaked at $3.07M in Q4 2013. 508 funds tracked by Wall St. Rank hold HALO as of Q4 2024.

  • Group One Trading reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 9,855 Halozyme shares in Q4 2024, an estimated $505K.
  • Group One Trading first reported a position in Halozyme in Q2 2013 and held it in 22 quarters.
  • Group One Trading's Halozyme position peaked at $3.07M in Q4 2013.
  • 508 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.